Kyung-Ha Lee

Kyung-Ha Lee

Chief Executive Officer presso JW HOLDINGS CORPORATION

Patrimonio netto: 52 M $ in data 31/03/2024

60 anni
Health Technology
Consumer Services
Finance

Profilo

Kyung-Ha Lee is currently the Co-Chief Executive Officer & Director at JW HOLDINGS Corp.
and the Co-Chief Executive Officer at Theriac Pharma Corp.
He is also the Chairman of JW PHARMACEUTICAL Corp., the Director of JW Medical Ltd., and the Director of C&C Research Laboratories.
Previously, he served as the Vice Chairman of JW SHINYAK Corp.
from 2014 to 2015 and as a Director at JW Life Science Corp.
Mr. Lee holds an MBA from Drake University and an undergraduate degree from Sungkyunkwan University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
27/03/2024 21 015 544 ( 28.43% ) 49 M $ 31/03/2024
01/01/2024 142 160 ( 0.61% ) 3 M $ 31/03/2024

Posizioni attive di Kyung-Ha Lee

SocietàPosizioneInizio
JW PHARMACEUTICAL CORPORATION Chairman -
JW HOLDINGS CORPORATION Chief Executive Officer -
Director/Board Member -
Director/Board Member -
Theriac Pharma Corp. Chief Executive Officer -
Tutte le posizioni attive di Kyung-Ha Lee

Precedenti posizioni note di Kyung-Ha Lee

SocietàPosizioneFine
JW SHINYAK CORPORATION Chief Executive Officer 21/03/2014
JW LIFESCIENCE CORPORATION Director/Board Member -
Vedi nel dettaglio l'esperienza di Kyung-Ha Lee

Formazione di Kyung-Ha Lee

Drake University Masters Business Admin
Sungkyunkwan University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kyung-Ha Lee

Relazioni

20

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
JW SHINYAK CORPORATION

Health Technology

JW HOLDINGS CORPORATION

Health Technology

JW LIFESCIENCE CORPORATION

Health Technology

Aziende private4
JW PHARMACEUTICAL Corp.

Finance

Health Technology

Theriac Pharma Corp.

Vedi le connessioni aziendali